Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C25H20F4N4O3S |
| Molecular Weight | 532.51 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CS(=O)(=O)C1=CC=CC=C1C2=CC=C(NC(=O)C3=CC(=NN3C4=CC=CC(CN)=C4)C(F)(F)F)C(F)=C2
InChI
InChIKey=ZLUOAFAJSUPHOG-UHFFFAOYSA-N
InChI=1S/C25H20F4N4O3S/c1-37(35,36)22-8-3-2-7-18(22)16-9-10-20(19(26)12-16)31-24(34)21-13-23(25(27,28)29)32-33(21)17-6-4-5-15(11-17)14-30/h2-13H,14,30H2,1H3,(H,31,34)
| Molecular Formula | C25H20F4N4O3S |
| Molecular Weight | 532.51 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Discovery of 1-[3-(aminomethyl)phenyl]-N-3-fluoro-2'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423), a highly potent, selective, and orally bioavailable inhibitor of blood coagulation factor Xa. | 2001 Feb 15 |
|
| Formation of unusual glutamate conjugates of 1-[3-(aminomethyl)phenyl]-N-[3-fluoro-2'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC 423) and its analogs: the role of gamma-glutamyltranspeptidase in the biotransformation of benzylamines. | 2001 Oct |
|
| Nonpeptide factor Xa inhibitors III: effects of DPC423, an orally-active pyrazole antithrombotic agent, on arterial thrombosis in rabbits. | 2002 Dec |
|
| DPC-423 Bristol-Myers Squibb. | 2002 Feb |
|
| P450-mediated metabolism of 1-[3-(aminomethyl)phenyl]-N-[3-fluoro-2'-(methylsulfonyl)- [1,1'-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole- 5-carboxamide (DPC 423) and its analogues to aldoximes. Characterization of glutathione conjugates of postulated intermediates derived from aldoximes. | 2002 Jan |
|
| Disposition of 1-[3-(aminomethyl)phenyl]-N-[3-fluoro-2'- (methylsulfonyl)-[1,1'-biphenyl]-4-yl]-3-(trifluoromethyl)- 1H-pyrazole-5-carboxamide (DPC 423) by novel metabolic pathways. Characterization of unusual metabolites by liquid chromatography/mass spectrometry and NMR. | 2002 Jan |
|
| Nonpeptide factor Xa inhibitors: DPC423, a highly potent and orally bioavailable pyrazole antithrombotic agent. | 2002 Summer |
|
| Development and validation of a liquid chromatography-mass spectrometric method for the determination of DPC 423, an antithrombotic agent, in rat and dog plasma. | 2003 Jan 5 |
|
| Phenyltriazolinones as potent factor Xa inhibitors. | 2010 Feb 15 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 08:26:52 GMT 2023
by
admin
on
Sat Dec 16 08:26:52 GMT 2023
|
| Record UNII |
XXQ8EQ9VMM
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
209957-47-1
Created by
admin on Sat Dec 16 08:26:52 GMT 2023 , Edited by admin on Sat Dec 16 08:26:52 GMT 2023
|
PRIMARY | |||
|
XXQ8EQ9VMM
Created by
admin on Sat Dec 16 08:26:52 GMT 2023 , Edited by admin on Sat Dec 16 08:26:52 GMT 2023
|
PRIMARY | |||
|
9895762
Created by
admin on Sat Dec 16 08:26:52 GMT 2023 , Edited by admin on Sat Dec 16 08:26:52 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
